skwestorange

Comment Stream » BMY

Comment Stream
Filter comments by:
Highest rated Latest comments
  • Current Yields Makes Bristol Myers Squibb a Buy
    Absent a good review of the strength of the pipeline, i.e., the number phase 3 clinicals and their probabilities of success in terms of substantial revenue in the near to intermediate term, this article fails to add any value. I agree with MD.
    May 22 17:01 pm |Rating: 0 0 |Link to Comment |View article

skwestorange's Comments Stream Stats

  • 43 Comments, 10 , 3
  • Total Comment Stream rating - = 7